INDEX VENTURES LIFE VI (JERSEY) L.P. - 27 May 2021 Form 3/A - Amendment Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
10%+ Owner
Signature
Index Ventures Life VI (Jersey) LP, By: Index Venture Life Associates VI Limited, By: /s/ David Middleton, Its: Director
Issuer symbol
CNTA
Transactions as of
27 May 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
03 Jun 2021, 10:12:14 UTC
Date Of Original Report
27 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTA Ordinary Shares 9,812,368 27 May 2021 Direct F1, F2, F3
holding CNTA Ordinary Shares 149,421 27 May 2021 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering ("IPO").
F2 Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 Held by Index Ventures Life VI (Jersey) LP, a Jersey limited partnership ("Index Ventures Life VI"). Index Venture Life Associates VI Limited, a Jersey limited liability company ("Index Venture Life VI GP"), is the managing general partner of Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Index Ventures Life VI, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
F4 Held by Yucca (Jersey) SLP, a Jersey separate limited partnership ("Yucca"). Yucca administers the Index Ventures Life VI co-investment vehicle that is contractually required to mirror the investment in the shares by Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Yucca, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.

Remarks:

Medicxi Ventures (UK) LLP and Medicxi Ventures (Jersey) Limited act as sub-advisers to Index Ventures Life VI (Jersey) Limited, which acts as the adviser to Index Ventures Life VI, and as such, certain funds affiliated with Medicxi, which hold Ordinary Shares and/or Series A Preferred Shares as of the date hereof, and Index Ventures Life VI and Yucca (Jersey) SLP, may be deemed to be members of a "group" as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended. This amendment to Form 3 is being filed to include Index Venture Life VI GP as a Reporting Person.